Foundation Fighting Blindness and Vitrisa Therapeutics Collaborate in Developing Innovative Clinical Trial Designs for Stargardt Disease Treatments

Originally published on this site - link to post

 Results from ProgStar, FFB’s natural history study for people with Stargardt disease, to be used in Vitrisa’s simulation of clinical trial designs for potential therapies

Leave a Comment

Your email address will not be published. Required fields are marked *